Phase I/II Clinical Drug Trials is a quick, easy-to-use source of data, an indispensable guide, readily providing the information needed to make crucial decisions regarding drug therapies. This book makes it easy to plan cost-effective, early drug development programs. The first four sections of the text deal with the preliminaries to studying drugs in humans, as well as considerations common to early drug trials in human subjects. Part II considers organization and decision making factors. Ethical and legal considerations are discussed in the next section. Subsequent chapters deal with specific therapeutic areas and indications. Areas of growing importance, such as studying in vitro metabolism in human hepatocytes and genetic engineering are highlighted as well.
FREE Two-Day Shipping for Students. Learn more |
 Sell Back Your Copy for $2.00
Whether you buy it used on Amazon for $49.93 or somewhere else, you can sell it back through our Book Trade-In Program at the current price of $2.00.
Used Price$49.93
Trade-in Price$2.00
Price after
Trade-in$47.93 |
Book Description
Product Details
Would you like to update product info or give feedback on images?
|
Customer Reviews
|
There are no customer reviews yet.
|
|||
|
Video reviews
|
Inside This Book
(learn more)
First Sentence:
The primary goal of most research-based pharmaceutical organizations around the world is to discover, develop, and procure necessary regulatory approvals for marketing new drugs for the treatment or prevention of diseases in humans and animals. Read the first page Key Phrases - Statistically Improbable Phrases (SIPs): (learn more)
new antiparkinsonian drugs, early patient studies, indicator dye dilution technique, claudication studies, scopolamine model, intermittant claudication, anthralin inflammation, drug disposition studies, unwanted drug effects, repeatability coefficient, computerized assessment system, antisecretory effect, antisecretory activity, healthy volunteer studies, clinical drug trials, antidepressant drug trials, antidementia drugs, cellular exfoliation, tolerability study, early phase studies, secondary pharmacology, new antibacterial agent, inhibition zone diameters, chronic viral illnesses, investigator costs Key Phrases - Capitalized Phrases (CAPs): (learn more)
Handbook of Phase, New York, Department of Health, Agents Chemother, Royal College of Physicians, Declaration of Helsinki, Raven Press, European Commission, Medicines Act, Pharmacodynamic Issues, World Health Organization, Drug Metab, Medical Research Council, North America, Acta Derm, Marcel Dekker, Mueller Hinton, Academic Press, Acta Psychiatr, American Heart Association, Dermatology Volume, Government Printing Office, Handbook of Experimental Pharmacology Vol, Martinus Nijhoff, Oxford University Press New!
Books on Related Topics | Concordance | Text Stats Browse Sample Pages:
Front Cover | Table of Contents | First Pages | Index | Back Cover | Surprise Me!
The primary goal of most research-based pharmaceutical organizations around the world is to discover, develop, and procure necessary regulatory approvals for marketing new drugs for the treatment or prevention of diseases in humans and animals. Read the first page Key Phrases - Statistically Improbable Phrases (SIPs): (learn more)
new antiparkinsonian drugs, early patient studies, indicator dye dilution technique, claudication studies, scopolamine model, intermittant claudication, anthralin inflammation, drug disposition studies, unwanted drug effects, repeatability coefficient, computerized assessment system, antisecretory effect, antisecretory activity, healthy volunteer studies, clinical drug trials, antidepressant drug trials, antidementia drugs, cellular exfoliation, tolerability study, early phase studies, secondary pharmacology, new antibacterial agent, inhibition zone diameters, chronic viral illnesses, investigator costs Key Phrases - Capitalized Phrases (CAPs): (learn more)
Handbook of Phase, New York, Department of Health, Agents Chemother, Royal College of Physicians, Declaration of Helsinki, Raven Press, European Commission, Medicines Act, Pharmacodynamic Issues, World Health Organization, Drug Metab, Medical Research Council, North America, Acta Derm, Marcel Dekker, Mueller Hinton, Academic Press, Acta Psychiatr, American Heart Association, Dermatology Volume, Government Printing Office, Handbook of Experimental Pharmacology Vol, Martinus Nijhoff, Oxford University Press New!
Books on Related Topics | Concordance | Text Stats Browse Sample Pages:
Front Cover | Table of Contents | First Pages | Index | Back Cover | Surprise Me!
Books on Related Topics
(learn more)
|
Tag this product(What's this?)Think of a tag as a keyword or label you consider is strongly related to this product.
Tags will help all customers organize and find favorite items. |
Sell a Digital Version of This Book in the Kindle Store
If you are a publisher or author and hold the digital rights to a book, you can sell a digital version of it in our Kindle Store.
Learn more
Customer Discussions
|
This product's forum
Active discussions in related forums
Search Customer Discussions
|
Related forums
|
